Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension I: Introduction01:28

Hypertension I: Introduction

74
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
74
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

42
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
42
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

38
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
38
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

3.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.1K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

77
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
77
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

48
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
48

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Response to "Quantifying the population burden of hypertension: methodological considerations on the PAF analysis of the DeSC cohort".

Hypertension research : official journal of the Japanese Society of Hypertension·2026
Same author

Identification of AMPD2 allosteric inhibitors with novel mechanism of action by fragment merging approach.

SLAS discovery : advancing life sciences R & D·2026
Same author

An air-electrode with hierarchically continuous pore architecture: a step toward "true" lithium-air batteries working with atmospheric oxygen.

Science and technology of advanced materials·2026
Same author

Acute Physiological and Emotional Responses to a Brief 24-Minute Yoga Session: Randomized Exploratory Pilot Study With Waitlist Comparison.

JMIR formative research·2026
Same author

Impact of Genetic Testing Among Patients With Familial Hypercholesterolemia on Adverse Cardiovascular Events　- The Hokuriku-Plus Familial Hypercholesterolemia Registry Study.

Circulation journal : official journal of the Japanese Circulation Society·2026
Same author

Clinical Trial on the Usefulness of an Intensive Low-Density Lipoprotein Cholesterol Treatment and Familial Hypercholesterolemia Screening Clinical Pathway for Acute Coronary Syndrome: The Hokuriku-plus Acute Coronary Syndrome Registry Study　- Rationale and Study Design.

Circulation reports·2026
Same journal

Is phosphate burden an under-recognized driver of apparent treatment-resistant hypertension in CKD?

Hypertension research : official journal of the Japanese Society of Hypertension·2026
Same journal

Comment on: Impact of stent materials and hemodynamic changes after endovascular aneurysm repair for abdominal aortic aneurysm.

Hypertension research : official journal of the Japanese Society of Hypertension·2026
Same journal

Association between hypertension and incidence of cardiovascular disease events in young adults with type 2 diabetes: a nationwide cohort study.

Hypertension research : official journal of the Japanese Society of Hypertension·2026
Same journal

Association between hypertension phenotypes and aortic valve peak velocity: a potential tool for identifying white-coat hypertension.

Hypertension research : official journal of the Japanese Society of Hypertension·2026
Same journal

Randomized-controlled trial of sacubitril/valsartan and amlodipine combination in Japanese uncontrolled hypertensive patients (J-SAMIT).

Hypertension research : official journal of the Japanese Society of Hypertension·2026
Same journal

Pleiotropic effects of renal denervation beyond blood pressure reduction.

Hypertension research : official journal of the Japanese Society of Hypertension·2026
See all related articles

Related Experiment Video

Updated: Sep 10, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

848

The JSH Morning Hypertension Eradication Program Project.

Kazuomi Kario1, Akira Nishiyama2, Shigeru Shibata3

  • 1Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan. kkario@jichi.ac.jp.

Hypertension Research : Official Journal of the Japanese Society of Hypertension
|August 26, 2025
PubMed
Summary
This summary is machine-generated.

Managing early morning hypertension is crucial for cardiovascular health in Japan. The Japanese Society of Hypertension

Keywords:
AsakatsuMorning Hypertension Eradication Programguidelineimplementation hypertensionkiosk blood pressure

More Related Videos

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

324
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

654

Related Experiment Videos

Last Updated: Sep 10, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

848
Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

324
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

654

Area of Science:

  • Cardiovascular Medicine
  • Hypertension Research
  • Public Health Initiatives

Background:

  • Hypertension is a leading risk factor for cardiovascular diseases and mortality.
  • In Japan, 43 million people have hypertension, with only 27% achieving controlled blood pressure (BP).
  • Major cardiovascular events often occur in the early morning hours.

Discussion:

  • The Japanese Society of Hypertension (JSH) guidelines emphasize home BP monitoring for managing early morning hypertension.
  • Despite multiple medications, fewer than 30% of hypertensive patients achieve morning BP targets (<130/80 mmHg).
  • JSH declared 2025 the year for eradicating morning hypertension, releasing new guidelines.

Key Insights:

  • The Asakatsu BP Action Plan encourages widespread morning BP monitoring.
  • JSH's Systematic Review and Data Science Projects aim to increase awareness and leverage digital health.
  • Focus on personalized and anticipatory medicine through "digital hypertension" research.

Outlook:

  • The initiative aims to significantly improve morning BP control nationwide.
  • International collaboration will be sought to address early morning hypertension globally.
  • Digital technology integration promises advancements in hypertension management and prevention.